Kai Wen Teng

机构：Yunnan University, China Tobacco, Powerchina Huadong Engineering Corporation (China) · ORCID：0000-0001-6898-9642

发表论文 53 篇 · 总被引 1182 次 · h-index 17

代表论文

• Selective and noncovalent targeting of RAS mutants for inhibition and degradation (2021 · Nature Communications · 被引 87)
• Antibody isotype diversity against SARS-CoV-2 is associated with differential serum neutralization capacities (2021 · Scientific Reports · 被引 52)
• Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors (2023 · Proceedings of the National Academy of Sciences · 被引 35)
• Excellent antibiotic degradation through PMS activation via bio derived Fe-Mn oxides with tunable defect concentration: Synergy between singlet oxygen oxidation and electron transfer (2024 · Journal of environmental chemical engineering · 被引 25)
• Monobodies as tool biologics for accelerating target validation and druggable site discovery (2021 · RSC Medicinal Chemistry · 被引 25)
• Inhibition of RAS-driven signaling and tumorigenesis with a pan-RAS monobody targeting the Switch I/II pocket (2022 · Proceedings of the National Academy of Sciences · 被引 24)